A patient journey in the changing landscape of AMD

  • Novel pharmacotherapies for wet AMD
  • Rethinking the treatment regimens
  • When a switch is needed: new options and new parameters
  • When both wet AMD and GA treatment are needed
  • Artificial Intelligence and home monitoring
A joint project of IVEG and Floretina

 


Previous webcasts

The long-term impact of the pandemic in the management of retinal pathologies

LEARN MORE

Managing retina patient flow in the COVID-19 era

LEARN MORE

Remote monitoring in the management of retinal disease

LEARN MORE

Management of retinal disease in the time of COVID-19 – Present and future challenges

LEARN MORE